Evidence map›Paper›PMID 34517824›Full record

ArticleBMC infectious diseases2021

Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses.

Dorthe Raben, Jordi Casabona, Lella Cosmaro, Nadia Gasbarrini, John S Lambert, Shannon Glapsy, Christine Kakalou, Manuel Maffeo, Michele Mommi, Gianmarco Corradini and 14 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Dorthe RabenCHIP, Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. Dorthe.raben@regionh.dk.
Jordi CasabonaCentre for Epidemiological Studies on STI/HIV/AIDS in Catalonia (CEEISCAT), Institut Josep Carreras, Campus de Can Ruti, Ctra de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Catalonia, Spain.
Lella CosmaroFondazione LILA Milano - Italian League for Fighting AIDS, Via Carlo Maderno 4, 20136, Milan, MI, Italy.
Nadia GasbarriniFondazione Villa Maraini, Via Bernardino Ramazzini, 31 -, 00151, Rome, RM, Italy.
John S LambertMater Misericordiae University Hospital and UCD School of Medicine, Belfield, Dublin 4, Ireland.
Shannon GlapsyMater Misericordiae University Hospital and UCD School of Medicine, Belfield, Dublin 4, Ireland.
Christine KakalouCentre for Research & Technology Hellas, Institute of Applied Biosciences, 6th km Charilaou-Thermi Rd, P.O. Box 60361, 57001, Thessaloniki, GR, Greece.
Manuel MaffeoArcigay Associazione LGBTI Italiana, Via Don Minzoni 18, 40121, Bologna, Italy.
Michele MommiArcigay Associazione LGBTI Italiana, Via Don Minzoni 18, 40121, Bologna, Italy.
Gianmarco CorradiniArcigay Associazione LGBTI Italiana, Via Don Minzoni 18, 40121, Bologna, Italy.
Irena KlavsNational Institute of Public Health, Trubarjeva 2, 1000, Ljubljana, Slovenia.
Aljona KurbatovaNational Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia.
Iwona WawerNational AIDS Centre, Agency of the Ministry of Health, Samsonowska 1, 02-829, Warszawa, Poland.
Piotr WysockiNational AIDS Centre, Agency of the Ministry of Health, Samsonowska 1, 02-829, Warszawa, Poland.
Anne RaahaugeCHIP, Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
Stine Finne JakobsenCHIP, Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
Jeffrey V LazarusBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Calle del Rossellon 132, ES-08036, Barcelona, Spain.
Ann SullivanChelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London, London, SW10, UK.
Meaghan KallPublic Health England, Wellington House 133-155 Waterloo Road, London, SE1 8UG, UK.
Dagmar HedrichEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289, Lisbon, Portugal.
Cheryl Case JohnsonWorld Health Organisation (WHO) Regional Office for Europe, FN Byen, Marmorvej 51, 2100, Copenhagen, Denmark.
Nicole Simone SeguyWorld Health Organisation (WHO) HQ, Avenue Appia 20, 1202, Geneva, Switzerland.
Daniel SimõesGrupo de Ativistas em Tratamentos (GAT), Avenida Paris, 4 - 1 Direito, 1000-228, Lisbon, Portugal.
Valerie DelpechPublic Health England, Wellington House 133-155 Waterloo Road, London, SE1 8UG, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Communicable DiseasesHIV InfectionsSexually Transmitted DiseasesData CollectionHumansEuropeHIVIntegrated servicesSexually transmitted infectionsTuberculosisViral hepatitis

Identifiers

PMID34517824
PMCPMC8436854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.